Medscape Multivariable models were adjusted for age , sex, race, education level, household net worth, region of residence at the time of medical plan enrollment, time-dependent use of nonstatin cholesterol-lowering medications, ocular comorbid conditions ...
DigitalJournal.com (press release) Plaintiffs across the country are filing Lipitor lawsuits, many of which are under consideration for consolidation into a federal multidistrict litigation for efficient pretrial proceedings (In re Lipitor ( Atorvastatin ) Litigation, MDL No. 2459 ...
Business Standard According to analyst at Karvy Broking, the pharmaceutical company will report revenue growth of 11.9% yoy at Rs 2,974 crore aided by US due to Propecia launch, scale up in Atorvastatin and Metaprolol. Net profit is likely to grow 18% at Rs 405 crore on ... and more »
pharmabiz.com The sales in North America declined to Rs.689 crore from Rs.2,093 crore in the same quarter of last year as it included sales of two exclusivity viz., atorvastatin and amlodipine plus atorvastatin . Its sales in US amounted to Rs.596 crore. The ...
Richmond Times Dispatch (blog) ... get prices on a month's supply of five blockbuster drugs that recently became available as generics: Actos (pioglitazone), for diabetes; Lexapro (escitalopram), an antidepressant; Lipitor ( atorvastatin ), for high cholesterol; Plavix (clopidogrel ... and more »
Forbes Remember also that the leading medications for high blood pressure (amlodipine), high cholesterol ( atorvastatin ), diabetes (metformin), and depression (citalopram) are all generic. It's literally more expensive to make a six-pack of Coke than to make a ... and more »
PipelineReview.com (press release) LIPTRUZET (pronounced LIP-true-zett) contains ezetimibe, an efficacious LDL cholesterol lowering therapy, and atorvastatin , currently one of the most widely prescribed statins in the U.S.[1] Once-daily LIPTRUZET treats two sources of cholesterol by ...
Clinical Endocrinology News Digital Network Since the results of the ENHANCE (Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression) study were released in 2008, the value of adding ezetimibe has been questioned. In that controversial study, the combination of ... and more »
Pharmacy News After reaping the benefits of its head start in the generic market for atorvastatin , Ranbaxy Laboratories has reported a 90 per cent drop in first quarter net profit compared with the first quarter 2012. The generic drug manufacturer said its ...
